Hepatitis C treatment has undergone a remarkable transformation New antiviral medications offer shorter more effective ...

A novel approach developed by a UB physician-scientist and colleagues to cure hepatitis C virus in people with opioid use ...

A team of researchers from the University of Florida has developed an innovative handheld device for human immunodeficiency ...

Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...

Your liver is not just responsible for converting nutrients, removing toxins from the blood, and controlling blood sugar—it also makes sure you are healthy and fit. Damage to this organ has serious ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the firm, MarketBeat reports.

JMP Securities reaffirmed their market outperform rating on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a report released on Tuesday,Benzinga reports. JMP Securities currently has ...

The largest conference of HIV medical experts and scientists in India this year, the 16th National Conference of AIDS Society ...

Considered once to be a lifelong disease, Hepatitis C has now been treated and cured in 1,000 patients at Kaiser Permanente.

Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...

The Kaiser Permanente Hawaii Viral Hepatitis Clinic reached a milestone by curing its 1,000th patient of hepatitis C. “It’s a very satisfying thing to make that call and tell someone they’re cured,” ...